CAS: 1043854-13-2
Ref: IN-DA01V2YA
| 5mg | 118.00 € | ||
| 10mg | 156.00 € | ||
| 25mg | 178.00 € | ||
| 50mg | 282.00 € | ||
| 100mg | 598.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Apr 2025
Ref: 54-OR1023950
| 1g | 1,402.00 € | ||
| 100mg | 479.00 € | ||
| 250mg | 753.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
Ref: 54-BUP12953
| 1g | 2,217.00 € | ||
| 25mg | 241.00 € | ||
| 50mg | 350.00 € | ||
| 100mg | 583.00 € | ||
| 500mg | 1,150.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025
J14
CAS:1043854-13-2
J-14, a reversible sulfiredoxin inhibitor (IC50: 8.1 μM), triggers oxidative stress and cancer cell death.
Formula:
C28H25ClN4O2S
Purity:
96.93% - 97.81%
Color and Shape:
Solid
Molecular weight:
517.04
Ref: TM-T8320
| 2mg | 49.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 156.00 € | ||
| 50mg | 230.00 € | ||
| 100mg | 390.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025
J14
CAS:1043854-13-2
Please enquire for more information about J14 including the price, delivery time and more detailed …
Formula:
C28H25ClN4O2S
Purity:
Min. 95%
Molecular weight:
517 g/mol
Ref: 3D-TRB85413
| 50mg | 803.00 € | ||
| 100mg | 1,212.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
4-(((4-(4-(2-Chlorophenyl)piperazin-1-yl)-6-phenylpyrimidin-2-yl)thio)methyl)benzoic acid
CAS:1043854-13-2
Purity:
99.0%
Molecular weight:
517.0399780273438
Ref: 10-F547027
| 1g | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
